Insilico Medicine vs Veeva Systems
Relationship
Assembled from the recorded fields for this pair, not hand-checked. The comparison below is read from each company’s own profile.
Aligned comparison
Capability overlap
Shared · 3
Not verified for Veeva Systems · 5
Recorded for Insilico Medicine. Veeva Systems’s product records say nothing either way — a missing record is not a missing capability.
Not verified for Insilico Medicine · 7
Recorded for Veeva Systems. Insilico Medicine’s product records say nothing either way — a missing record is not a missing capability.
Products, side by side
Algorithmic pairing — assembled from recorded fields, not hand-checked
Insilico Medicine
Application
AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.
Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.
Veeva Systems
Application
An embedded suite of AI agents for Veeva Vault PromoMats, including a Quick Check Agent for automated document quality checks and a conversational Content Agent that guides reviewers, plus configurable custom agents.
Conversational AI brand engagement platform for life sciences that answers patient and HCP questions on brand sites and over email using MLR-approved content, and captures the resulting engagement as commercial evidence.
No counterpart
Insilico Medicine sells these in a stack layer with no product recorded for Veeva Systems yet — nothing on the other side to compare them against.
Platform
AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.
Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.
Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.
AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base.
End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.
Hardware
On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.
Veeva Systems sells these in a stack layer with no product recorded for Insilico Medicine yet — nothing on the other side to compare them against.
AI agent
Agentic labor platform providing standard biopharma AI agents that execute end-to-end clinical, regulatory and safety processes such as TMF intake and QC, health authority correspondence, and safety case triage.
Agentic medical, legal and regulatory review product that automatically checks promotional content for compliance across markets, anchors claims to references, and connects into the Veeva PromoMats review workflow.
Agent platform
Agentic layer across Veeva's Vault platform, with industry-specific agents that reach a life-sciences customer's regulated documents, CRM records and workflows directly rather than through an export.